Company Overview and News


Add LUPIN
to your dashboard

Headline News

Update On Aralez Pharmaceuticals

2017-07-06 seekingalpha
As well, Yosprala sales have improved following recent marketing and pricing strategy changes, but remain a question mark.

Sun Pharma buys 14 of Novartis’s brands in Japan for $293 mn

2016-03-29 livemint
Acquisition of prescription brands, with annualized revenues of $160 million, marks Sun Pharma’s entry into the Japanese market

Volatile within a range; Sensex and Nifty end lower

2016-03-29 indiainfoline
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.

India's Lupin says it sees no supply disruption at plant despite FDA observations

2016-03-29 channelnewsasia
MUMBAI: Lupin Ltd, India's third-largest drugmaker, said on Tuesday it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the U.S. Food and Drug Administration after an audit.

USFDA issues Form 483 to Lupin’s plant, stock dips 12%

2016-03-29 livemint
USFDA issued its Form 483 to Lupin, conveying its concerns about manufacturing practices at the Mandideep plant, according to the report

Lupin shares plunge 8% on US FDA’s observations on Goa unit

2016-03-16 freepressjournal.in
Drugmaker putting together a response to address the US FDA’s observations; analysts are unsure whether the observations made by the regulator would invite stringent action

Lupin completes acquisition of GAVIS

2016-03-09 thehindubusinessline
Pharmaceutical major Lupin said it has completed its acquisition of pr

Lupin's subsidiary to set up plant in Japan

2016-02-29 moneycontrol
In order to meet the rapidly growing demand of generics, the Kyowa board has proposed the setting-up of a two billion tablets capacity plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion, Lupin Ltd said in a regulatory filing...

FIPB to take up 33 investment proposals on March 7

2016-02-28 moneycontrol
The investment proposals of Nippon Life Insurance Company, Tata AIA Life Insurance Company and Aviva Life Insurance Co lndia are on the agenda of the 232nd meeting of the Foreign Investment Promotion Board (FIPB)...

FIPB to take up 33 investment proposals on March 7

2016-02-28 thehindubusinessline
Inter-ministerial panel FIPB will take a call on 33 foreign investment proposals, incl

IN RE: LOESTRIN 24 FE ANTITRUST LITIGATION. American Sales Company

2016-02-24 caselaw.findlaw
FindLaw's searchable database of United States First Circuit decisions since

Top 10 stocks in focus today: Punjab National Bank, Alstom T&D and more

2016-02-24 financialexpress
PNB Stocks were trading 3.23 per cent down at Rs 70.35 in early trade after it declared a list of about 900 wilful defaulters including Winsome Diamonds & Jewellery, Zoom Developers and Nafed, which owe close to Rs 11,000 crore to the lender.

US and EU regulators urge Indian drug cos to step up standards

2016-02-24 moneycontrol
India's USD 15 billion pharmaceutical industry, an increasingly important global supplier of cheaper generic medicines, has been dogged by concerns over quality issues after the US Food and Drug Administration banned a series of factories from producing medicines for the United States due to inadequate standards...

US and EU regulators urge Indian drug companies to step up standards

2016-02-23 reuters
MUMBAI U.S. and EU drug regulators called upon India's pharmaceutical sector on Tuesday to step up efforts to improve manufacturing standards and ensure the reliability of data if it is to maintain its dominance in the generic drugs industry.

U.S. and EU regulators urge Indian drug companies to step up standards

2016-02-23 in.reuters
MUMBAI U.S. and EU drug regulators called upon India's pharmaceutical sector on Tuesday to step up efforts to improve manufacturing standards and ensure the reliability of data if it is to maintain its dominance in the generic drugs industry.